Skip to main content
  1. The latest HSBC Venture Healthcare report shows increased levels of investment in 2024 with Seed and ...
    • Gene/Cell Therapy
    Helex
    Helex is extending the frontier of breakthrough genetic medicines to meet the significant underserve ...
  2. Advances in neurodegenerative science have pointed to new paths in the development of medicines that ...
    • Platform for Therapeutics
    Nalu Bio
    A female-founded and led, San Francisco based biotech company, Nalu Bio is committed to transforming ...
    • Gene/Cell Therapy
    Coastar Therapeutics Inc.
    Coastar Therapeutics has pioneered a bioengineered cell membrane delivery platform facilitating gene ...
    • Oncology
    PTM Therapeutics, Inc.
    PTM Therapeutics was founded in 2020 based on the realization that post-translational modifications ...
  3. miRecule Inc.
    miRecule Inc. is a biotechnology company which develops highly tissue-targeted RNA therapeutics for ...
    • Metabolic Diseases
    Amaro Therapeutics, Inc.
    Amaro Therapeutics is an early-stage therapeutic platform company focused on the activation of ubiqu ...
    • Oncology
    Resolute Science, Inc.
    Resolute Science is a preclinical-stage biotechnology company developing a novel class of pan-cancer ...
    • Immunology
    Ziphius
    Ziphius is a preclinical biotech company specializing in vaccines and therapeutic drugs for infectio ...
  4. BIO has collaborated with a set of programs focused on entrepreneur development to curate an afterno ...
  5. APAC markets are among the largest and fastest growing in the world, with a legacy of successful int ...
  6. With oncology continuing to bear ripe opportunities for investors, new modalities such as antibody-d ...
  7. As the newest iterations of AlphaFold’s molecular modeling tool and ChatGPT’s language and coding mo ...
  8. In a highly competitive landscape, a compelling narrative that highlights your unique value proposit ...
  9. With the first pricing negotiation results of the Inflation Reduction Act now public, analysts will ...
  10. While the rate of IPOs this year is slightly increased versus 2023, the market is still much less ac ...
    • Oncology
    Kuda Therapeutics Inc
    Kuda Therapeutics is a Salt Lake City based oncology company focused on the development of first-in- ...
    • Oncology
    Geneos Therapeutics
    Phase 2 private biotech developing neoantigen targeted personalized therapeutic cancer vaccines (PTC ...
    • Multiple Therapeutics
    NovAb, Inc.
    NovAb is developing a new class of antibodies, variable lymphocyte receptors (“VLRs”), discovered by ...
    • Oncology
    Osmol Therapeutics, Inc.
    Osmol is a clinical stage biopharma company developing a first-in-class preventative treatment (OSM- ...
    • CNS/Neurological
    • Oncology
    Atheon Bio
    Atheon Bio is revolutionizing immune-oncology by pushing the limits of what was once thought impossi ...
    • Oncology
    • CNS/Neurological
    • Platform for Therapeutics
    • Platform for Therapeutics
    Aureka Biotechnologies, Inc.
    Aureka Biotechnologies is a premier biotech startup committed to democratizing the pharmaceutical in ...
    • Immunology
    Lmito Therapeutics Inc.
    Lmito is an innovation-driven biotechnology company dedicated to the development of novel and effect ...
    • CNS/Neurological
    Owl Therapeutics
    Owl Therapeutics – 1st FDA-Approved Drug for TBI - UNLOCKING WISDOM for BRAIN HEALTH Owl Therapeutic ...
    • Gene/Cell Therapy
    TiCARos
    TiCARos is a clinical-stage biopharmaceutical company focused on transforming cancer treatment throu ...
    • CNS/Neurological
    Nine Square Therapeutics
    Nine Square is developing novel treatments for neurodegenerative and age-related diseases by correct ...
    • Metabolic Diseases
    Seraxis, Inc.
    Seraxis is bringing transformative cures to the millions of T1D and insulin-requiring T2D patients w ...
    • CNS/Neurological
    Magdalena Biosciences, Inc
    Filament Health (Filament) and Jaguar Health (Jaguar) joined forces in early 2023 to create Magdalen ...
    • Tools/Drug Development Support Tech
    SPOC Proteomics Inc
    SPOC Proteomics Inc. is pioneering breakthroughs in proteomics with its foundational Sensor-Integrat ...
    • Oncology
    Phinomics
    Phinomics, a Stanford spin-off from Andrew Fire's Nobel Prize-winning laboratory (2006), was establi ...
    • Multiple Therapeutics
    AKSO Biopharmaceutical
    Drug-target binding affinity is pivotal in determining therapeutic efficacy. AKSO Bio's proprietary ...
    • Oncology
    CNCure Co., Ltd.
    CNCure Co., Ltd. is a pioneering biotech company, founded in 2019 and funded with $10M USD to date, ...
  11. BIO has collaborated with a set of programs focused on entrepreneur development to curate an afterno ...
    • Gene/Cell Therapy
    • Gene/Cell Therapy
    • Platform for Therapeutics
    • Oncology
    • Oncology
    • Oncology
    • Oncology
    • Oncology
    • Oncology
    • CNS/Neurological
    • CNS/Neurological

DOUBLE HELIX SPONSOR

HELIX SPONSOR

CONFERENCE SPONSORS